What should we prescribe for neuropsychiatric symptoms in Alzheimer’s disease?

shutterstock_70709260

Psychiatrist Andrés Fonseca considers how his clinical practice should change, after reading a systematic review and meta-analysis of drug treatment for neuropsychiatric symptoms in Alzheimer’s disease

[read the full story...]

Kinship care may be a viable out-of-home placement option for maltreated children, but more research is needed

shutterstock_128010446

Lisa Burscheidt reports on a recent Cochrane review that looks at the effects of kinship care versus traditional foster care for the safety, permanency and well-being of children removed from the home for maltreatment.

[read the full story...]

Outcome and methodological comparisons in psychotherapy and pharmacotherapy meta-analyses

shutterstock_128524325

Andrew Shepherd summarises a recent JAMA Psychiatry study looking at the efficacy of pharmacotherapy and psychotherapy for adult psychiatric disorders (and uses words like hubristic and existential quite a lot!)

[read the full story...]

Acamprosate and oral naltrexone may improve consumption related outcomes for people with alcohol use disorders

shutterstock_141815629

A new systematic review suggests that, when used alongside psychosocial interventions, medication can result in better alcohol consumption outcomes for people with drinking problems.

[read the full story...]

Antipsychotics and mood stabilisers may reduce violent crime

shutterstock_150668030

John Baker reports on the first population based report of the positive effects of antipsychotic medication and mood stabilisers on reducing the risk of a conviction for violent crime, published in the Lancet in May.

[read the full story...]

And if we do nothing? A new systematic review explores natural PTSD remission rates

shutterstock_68001577

Who naturally recovers from PTSD and why? A recent meta-regression analysis finds an overall natural remission rate for PTSD of 44%, with no increase in remission after longer observation periods.

[read the full story...]

Art therapy for schizophrenia: an effective add-on treatment?

matisse

The MATISSE trial in 2012 concluded that group art therapy did no better than standard care at improving symptoms for people with schizophrenia. A new critique of that RCT from the British Association of Art Therapists says the therapy can be more useful.

[read the full story...]

Health effects of depression: keeping economists’ models on track

shutterstock_169007078

Health Economist Christopher Sampson reports on a recent systematic review and meta-analysis, which shows health-related quality of life utility values vary between studies and economic models should consider this.

[read the full story...]